Ann: PARADIGM SUBMITS RESPONSES TO US FDA QUESTIONS, page-49

Goes to show you just how little the market knows or values PAR. What is PAR?
Who is PAR and possibly …
When is PAR?

I mean we are currently just another of many potential Ho hum OA solutions without real revenue.
Yes IND will change this but the real crux will happen after months not weeks… it will happen if our data trumps… I personally think it will, let’s see!

The good news is that we already have clues, answers before the final exam. You and I both know more about the Science than about 99% of shareholders and about 99.99998% of general population. This is called getting a head start!

The market one fine day will catch up, we will be ready!
PAR isn’t a company that chances it - it’s a company that plans, that anticipates… yes sure things can be tightened but I believe we have the ace staff to go beyond what is required leave aside the fundamental efficacy of the underlying drug!

Patience.

We need oodles… but in my opinion…. Just hold. Do not react.



DYOR